TEMPORAL-LOBE EPILEPSY - PRESURGICAL LOCALIZATION WITH PROTON CHEMICAL-SHIFT IMAGING

被引:131
作者
NG, TC
COMAIR, YG
XUE, M
SO, N
MAJORS, A
KOLEM, H
LUDERS, H
MODIC, M
机构
[1] CLEVELAND CLIN, DEPT NEUROSURG, CLEVELAND, OH 44195 USA
[2] CLEVELAND CLIN, DEPT NEUROPHYSIOL, CLEVELAND, OH 44195 USA
[3] CLEVELAND CLIN, DEPT NEUROL, CLEVELAND, OH 44195 USA
[4] SIEMENS AG, W-8520 ERLANGEN, GERMANY
关键词
BRAIN; MR; EPILEPSY; MAGNETIC RESONANCE (MR); CHEMICAL SHIFT; SEIZURES;
D O I
10.1148/radiology.193.2.7972764
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To assess two-dimensional phase-encoded proton chemical shift imaging for potential clinical application in presurgical localization of temporal lobe epilepsy (TLE). MATERIALS AND METHODS: Interictal chemical shift imaging studies were performed in 25 patients (17 unilateral, eight bilateral epileptogenic abnormalities) and 12 healthy volunteers. Results were compared with those of electroencephalography. For each temporal lobe, the volume of interest (VOI) included mesial, lateral, anterior, and posterior areas. RESULTS: The epileptogenic zone was characterized by an abnormal pattern of decreased signal intensity in the N-acetylaspartate (NAA) peak, either increased or unchanged choline (Cho) level relative to creatine (Cr) signal intensity, and, occasionally, elevated lactate level. NAA/Cho was the most sensitive and reliable quantitative marker for abnormality. The sensitivity and specificity of this technique compared with EEG were 90% and 85%, respectively. The difference in NAA/Cho between epileptogenic and normal temporal lobes was highly significant (P < .001). No statistically significant difference was found between normal temporal lobes and patients' uninvolved temporal lobes. CONCLUSION: NAA/Cho is an excellent marker for localizing the epileptogenic zone in TLE.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 49 条
[1]   METABOLISM OF HUMAN GLIOMAS - ASSESSMENT WITH H-1 MR SPECTROSCOPY AND F-18 FLUORODEOXYGLUCOSE PET [J].
ALGER, JR ;
FRANK, JA ;
BIZZI, A ;
FULHAM, MJ ;
DESOUZA, BX ;
DUHANEY, MO ;
INSCOE, SW ;
BLACK, JL ;
VANZIJL, PCM ;
MOONEN, CTW ;
DICHIRO, G .
RADIOLOGY, 1990, 177 (03) :633-641
[2]  
Arnold D L, 1990, NMR Biomed, V3, P184, DOI 10.1002/nbm.1940030407
[3]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, G ;
ANTEL, J .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) :154-159
[4]  
ARNOLD DL, 1992, 11TH P SMRM ANN M BE, P643
[5]   ACETYL TRANSPORT MECHANISMS - METABOLISM OF N-ACETYL-L-ASPARTIC ACID IN NON-NERVOUS TISSUES OF RAT [J].
BENUCK, M ;
DADAMO, AF .
BIOCHIMICA ET BIOPHYSICA ACTA, 1968, 152 (03) :611-&
[6]   METABOLISM OF N-ACETYL-L-ASPARTIC ACID IN MICE [J].
BERLINGUET, L ;
LALIBERTE, M .
CANADIAN JOURNAL OF BIOCHEMISTRY, 1966, 44 (06) :783-+
[7]   N-ACETYL-L-ASPARTIC ACID - A LITERATURE-REVIEW OF A COMPOUND PROMINENT IN H-1-NMR SPECTROSCOPIC STUDIES OF BRAIN [J].
BIRKEN, DL ;
OLDENDORF, WH .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1989, 13 (01) :23-31
[8]   MULTIPLE-SCLEROSIS IN CHILDREN - CEREBRAL METABOLIC ALTERATIONS MONITORED BY LOCALIZED PROTON MAGNETIC-RESONANCE SPECTROSCOPY INVIVO [J].
BRUHN, H ;
FRAHM, J ;
MERBOLDT, KD ;
HANICKE, W ;
HANEFELD, F ;
CHRISTEN, HJ ;
KRUSE, B ;
BAUER, HJ .
ANNALS OF NEUROLOGY, 1992, 32 (02) :140-150
[9]   NONINVASIVE DIFFERENTIATION OF TUMORS WITH USE OF LOCALIZED H-1 MR SPECTROSCOPY INVIVO - INITIAL EXPERIENCE IN PATIENTS WITH CEREBRAL-TUMORS [J].
BRUHN, H ;
FRAHM, J ;
GYNGELL, ML ;
MERBOLDT, KD ;
HANICKE, W ;
SAUTER, R ;
HAMBURGER, C .
RADIOLOGY, 1989, 172 (02) :541-548
[10]  
COMAIR YG, 1992, 1992 SOC MAGN RES ME, P1945